Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
A-Alpha Bio
4428
A-Alpha Bio
Health Care
Technology
Biotechnology
Research
AAlpha Bio is revolutionizing preclinical drug development. Our technology enables unprecedented characterization of proteinprotein interactions.
Suggest edits
Type
B2c
Founded
2017
Raised
$21M
Follow us
Also headquartered in Seattle
Amazon
GeekWire
Starbucks
Amazon Web Services
Zillow
Redfin
Bungie
Tableau
Gates Foundation
Bittrex
Companies in the same industry
Restored Hearing
KetoSwiss
Arbor Biotechnologies
Jellagen
Camallergy
Arctoris
bitBiome
TILT Biotherapeutics
Stimunity
Nemysis
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$20,000,000
Venture capital (Series A) - 2021
Madrona Venture Group
Lux Capital
Perceptive Advisors
$800,000
Grant - 2020
Bill & Melinda Gates Foundation
Team Size
1–10
Employees
I work here
Location
Seattle
,
United States
Headquarters
Explore Seattle
$20,000,000
Venture capital (Series A)
MedCity News
Startup A-Alpha Bio sets out to solve a major protein problem facing big pharma
$800,000
Grant
GeekWire
,
neurons.AI
Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research
$225,000
Grant
GeekWire
Clinical drug screening startup A-Alpha Bio awarded Small Business Innovation Research grant
GeekWire
Pre-clinical drug screening startup A-Alpha Bio wins first place at Univ. of Washington Business Plan Competition
Robotics
